The Rapid Growth of Remote Patient Monitoring Solutions Can Accelerate Decentralized Clinical Trials
Pharma companies and RPM manufacturers must work together to find solutions to make DCT more commonly available.
Dr. Ben Green
Advertisement
Articles by Dr. Ben Green
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist
2
Bringing a Breakthrough Rare Disease Product to Patients: Q&A with Helen Sabzevari
3
Boehringer Ingelheim Enters $1.26 Billion Collaboration and License Agreement with Simcere Pharmaceuticals to Develop Pre-Clinical Bispecific Antibody
4
Pharmaceutical Executive Daily: Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist
5